Global Market Report

Global Biologics (Biosimilar) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Mar 31, 2019
  • PAGES：152
  • REPORT CODE：GMM195547
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Biologics (Biosimilar) witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Biologics (Biosimilar) market is offered. The research provides insights for the global Biologics (Biosimilar) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Biologics (Biosimilar) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Biologics (Biosimilar) Market Segmentations:

    By Players:

    • Hospira

    • Mylan

    • Changchun High tech

    • Pfizer

    • 3sbio

    • Sandoz

    • Lilly

    • CP Guojian Pharmacy

    • Gelgen Biopharma

    • Merck

    • Johnson & Johnson

    • AbbVie

    • Novartis

    • Amgen

    • Roche

    • Novo Nordisk

    • Biotech Pharma

    • Sanofi

    • Teva


    By Types:

    • Recombinant Non-glycosylated Proteins

    • Recombinant Glycosylated Proteins


    By End-User:

    • Oncology

    • Blood Disorders

    • Growth Hormonal Deficiency

    • Chronic and Autoimmune Disorders

    • Others


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Biologics (Biosimilar) Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Biologics (Biosimilar) Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics (Biosimilar) Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Biologics (Biosimilar) Market Share by Types

      • 1.3.2 Global Biologics (Biosimilar) Market Size and Growth Rate of Recombinant Non-glycosylated Proteins from 2014 to 2026

      • 1.3.3 Global Biologics (Biosimilar) Market Size and Growth Rate of Recombinant Glycosylated Proteins from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Biologics (Biosimilar) Market Share by End-Users

      • 1.4.2 Global Biologics (Biosimilar) Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.3 Global Biologics (Biosimilar) Market Size and Growth Rate of Blood Disorders from 2014 to 2026

      • 1.4.4 Global Biologics (Biosimilar) Market Size and Growth Rate of Growth Hormonal Deficiency from 2014 to 2026

      • 1.4.5 Global Biologics (Biosimilar) Market Size and Growth Rate of Chronic and Autoimmune Disorders from 2014 to 2026

      • 1.4.6 Global Biologics (Biosimilar) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumBiologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Biologics (Biosimilar) Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biologics (Biosimilar) by Major Types

      • 3.4.1 Market Size and Growth Rate of Recombinant Non-glycosylated Proteins

      • 3.4.2 Market Size and Growth Rate of Recombinant Glycosylated Proteins


    4 Segmentation of Biologics (Biosimilar) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biologics (Biosimilar) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biologics (Biosimilar) for Oncology

      • 4.4.2 Market Size and Growth Rate of Biologics (Biosimilar) for Blood Disorders

      • 4.4.3 Market Size and Growth Rate of Biologics (Biosimilar) for Growth Hormonal Deficiency

      • 4.4.4 Market Size and Growth Rate of Biologics (Biosimilar) for Chronic and Autoimmune Disorders

      • 4.4.5 Market Size and Growth Rate of Biologics (Biosimilar) for Others


    5 Market Analysis by Major Regions

    • 5.1 Global Biologics (Biosimilar) Production Analysis by Major Regions

    • 5.2 Global Biologics (Biosimilar) Consumption Analysis by Major Regions

    • 5.3 Global Biologics (Biosimilar) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Biologics (Biosimilar) Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Biologics (Biosimilar) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Biologics (Biosimilar) Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Biologics (Biosimilar) Production, Import, Consumption and Export Analysis


    6 Product Commodity of Biologics (Biosimilar) Market in Major Countries

    • 6.1 Top 5 Export Countries in Biologics (Biosimilar) market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Biologics (Biosimilar) market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Biologics (Biosimilar) market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biologics (Biosimilar) market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Biologics (Biosimilar) market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Biologics (Biosimilar) market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Biologics (Biosimilar) Landscape Analysis

    • 7.1 North America Biologics (Biosimilar) Landscape Analysis by Major Types

    • 7.2 North America Biologics (Biosimilar) Landscape Analysis by Major End-Users

    • 7.3 North America Biologics (Biosimilar) Landscape Analysis by Major Countries

      • 7.3.1 United States Biologics (Biosimilar) Market Volume and Growth Rate

      • 7.3.2 Canada Biologics (Biosimilar) Market Volume and Growth Rate

      • 7.3.3 Mexico Biologics (Biosimilar) Market Volume and Growth Rate


    8 Europe Biologics (Biosimilar) Landscape Analysis

    • 8.1 Europe Biologics (Biosimilar) Landscape Analysis by Major Types

    • 8.2 Europe Biologics (Biosimilar) Landscape Analysis by Major End-Users

    • 8.3 Europe Biologics (Biosimilar) Landscape Analysis by Major Countries

      • 8.3.1 Germany Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.2 UK Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.3 France Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.4 Italy Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.6 Spain Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.7 Belgium Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.8 Poland Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.9 Russia Biologics (Biosimilar) Market Volume and Growth Rate

      • 8.3.10 Turkey Biologics (Biosimilar) Market Volume and Growth Rate


    9 Asia Pacific Biologics (Biosimilar) Landscape Analysis

    • 9.1 Asia Pacific Biologics (Biosimilar) Landscape Analysis by Major Types

    • 9.2 Asia Pacific Biologics (Biosimilar) Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Biologics (Biosimilar) Landscape Analysis by Major Countries

      • 9.3.1 China Biologics (Biosimilar) Market Volume and Growth Rate

      • 9.3.2 Japan Biologics (Biosimilar) Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Biologics (Biosimilar) Market Volume and Growth Rate

      • 9.3.4 India Biologics (Biosimilar) Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Biologics (Biosimilar) Market Volume and Growth Rate

      • 9.3.6 South Korea Biologics (Biosimilar) Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Biologics (Biosimilar) Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Biologics (Biosimilar) Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Biologics (Biosimilar) Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Biologics (Biosimilar) Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Biologics (Biosimilar) Market Volume and Growth Rate

      • 10.3.2 Brazil Biologics (Biosimilar) Market Volume and Growth Rate

      • 10.3.3 Nigeria Biologics (Biosimilar) Market Volume and Growth Rate

      • 10.3.4 South Africa Biologics (Biosimilar) Market Volume and Growth Rate 

      • 10.3.5 Argentina Biologics (Biosimilar) Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Hospira

      • 11.1.1 Hospira Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Mylan

      • 11.2.1 Mylan Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Changchun High tech

      • 11.3.1 Changchun High tech Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Pfizer

      • 11.4.1 Pfizer Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 3sbio

      • 11.5.1 3sbio Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Sandoz

      • 11.6.1 Sandoz Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Lilly

      • 11.7.1 Lilly Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 CP Guojian Pharmacy

      • 11.8.1 CP Guojian Pharmacy Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Gelgen Biopharma

      • 11.9.1 Gelgen Biopharma Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Merck

      • 11.10.1 Merck Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Johnson & Johnson

      • 11.11.1 Johnson & Johnson Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 AbbVie

      • 11.12.1 AbbVie Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Novartis

      • 11.13.1 Novartis Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Amgen

      • 11.14.1 Amgen Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Roche

      • 11.15.1 Roche Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Novo Nordisk

      • 11.16.1 Novo Nordisk Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 Biotech Pharma

      • 11.17.1 Biotech Pharma Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Sanofi

      • 11.18.1 Sanofi Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 Teva

      • 11.19.1 Teva Company Profile and Development Status

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 101 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Recombinant Non-glycosylated Proteins from 2014 to 2026

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Recombinant Glycosylated Proteins from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Blood Disorders from 2014 to 2026

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Growth Hormonal Deficiency from 2014 to 2026

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Chronic and Autoimmune Disorders from 2014 to 2026

    • Figure Global Biologics (Biosimilar) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Biologics (Biosimilar) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biologics (Biosimilar) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biologics (Biosimilar)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biologics (Biosimilar) by Different Types from 2014 to 2026

    • Table Consumption Share of Biologics (Biosimilar) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Recombinant Non-glycosylated Proteins

    • Figure Market Size and Growth Rate of Recombinant Glycosylated Proteins

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biologics (Biosimilar) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biologics (Biosimilar) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Blood Disorders

    • Figure Market Size and Growth Rate of Growth Hormonal Deficiency

    • Figure Market Size and Growth Rate of Chronic and Autoimmune Disorders

    • Figure Market Size and Growth Rate of Others

    • Table Global Biologics (Biosimilar) Production by Major Regions

    • Table Global Biologics (Biosimilar) Production Share by Major Regions

    • Figure Global Biologics (Biosimilar) Production Share by Major Regions in 2014

    • Figure Global Biologics (Biosimilar) Production Share by Major Regions in 2018

    • Figure Global Biologics (Biosimilar) Production Share by Major Regions in 2026

    • Table Global Biologics (Biosimilar) Consumption by Major Regions

    • Table Global Biologics (Biosimilar) Consumption Share by Major Regions

    • Figure Global Biologics (Biosimilar) Consumption Share by Major Regions in 2014

    • Figure Global Biologics (Biosimilar) Consumption Share by Major Regions in 2018

    • Figure Global Biologics (Biosimilar) Consumption Share by Major Regions in 2026

    • Table North America Biologics (Biosimilar) Production, Import, Consumption and Export Analysis

    • Table Europe Biologics (Biosimilar) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Biologics (Biosimilar) Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biologics (Biosimilar) market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biologics (Biosimilar) market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biologics (Biosimilar) market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biologics (Biosimilar) market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Biologics (Biosimilar) Consumption by Types from 2014 to 2026

    • Table North America Biologics (Biosimilar) Consumption Share by Types from 2014 to 2026

    • Figure North America Biologics (Biosimilar) Consumption Share by Types in 2014

    • Figure North America Biologics (Biosimilar) Consumption Share by Types in 2018

    • Figure North America Biologics (Biosimilar) Consumption Share by Types in 2026

    • Table North America Biologics (Biosimilar) Consumption by End-Users from 2014 to 2026

    • Table North America Biologics (Biosimilar) Consumption Share by End-Users from 2014 to 2026

    • Figure North America Biologics (Biosimilar) Consumption Share by End-Users in 2014

    • Figure North America Biologics (Biosimilar) Consumption Share by End-Users in 2018

    • Figure North America Biologics (Biosimilar) Consumption Share by End-Users in 2026

    • Table North America Biologics (Biosimilar) Consumption by Major Countries from 2014 to 2026

    • Table North America Biologics (Biosimilar) Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Biologics (Biosimilar) Consumption Share by Major Countries in 2014

    • Figure North America Biologics (Biosimilar) Consumption Share by Major Countries in 2018

    • Figure North America Biologics (Biosimilar) Consumption Share by Major Countries in 2026

    • Figure United States Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Biologics (Biosimilar) Consumption by Types from 2014 to 2026

    • Table Europe Biologics (Biosimilar) Consumption Share by Types from 2014 to 2026

    • Figure Europe Biologics (Biosimilar) Consumption Share by Types in 2014

    • Figure Europe Biologics (Biosimilar) Consumption Share by Types in 2018

    • Figure Europe Biologics (Biosimilar) Consumption Share by Types in 2026

    • Table Europe Biologics (Biosimilar) Consumption by End-Users from 2014 to 2026

    • Table Europe Biologics (Biosimilar) Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Biologics (Biosimilar) Consumption Share by End-Users in 2014

    • Figure Europe Biologics (Biosimilar) Consumption Share by End-Users in 2018

    • Figure Europe Biologics (Biosimilar) Consumption Share by End-Users in 2026

    • Table Europe Biologics (Biosimilar) Consumption by Major Countries from 2014 to 2026

    • Table Europe Biologics (Biosimilar) Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Biologics (Biosimilar) Consumption Share by Major Countries in 2014

    • Figure Europe Biologics (Biosimilar) Consumption Share by Major Countries in 2018

    • Figure Europe Biologics (Biosimilar) Consumption Share by Major Countries in 2026

    • Figure Germany Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure France Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Biologics (Biosimilar) Consumption by Types from 2014 to 2026

    • Table Asia Pacific Biologics (Biosimilar) Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by Types in 2014

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by Types in 2018

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by Types in 2026

    • Table Asia Pacific Biologics (Biosimilar) Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Biologics (Biosimilar) Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by End-Users in 2014

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by End-Users in 2018

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by End-Users in 2026

    • Table Asia Pacific Biologics (Biosimilar) Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Biologics (Biosimilar) Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Biologics (Biosimilar) Consumption Share by Major Countries in 2026

    • Figure China Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandBiologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure India Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Biologics (Biosimilar) Consumption Share by Major Countries in 2026

    • Figure GCC Countries Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Biologics (Biosimilar) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of Mylan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan

    • Figure Sales and Growth Rate Analysis of Mylan

    • Figure Revenue and Market Share Analysis of Mylan

    • Table Product and Service Introduction of Mylan

    • Table Company Profile and Development Status of Changchun High tech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Changchun High tech

    • Figure Sales and Growth Rate Analysis of Changchun High tech

    • Figure Revenue and Market Share Analysis of Changchun High tech

    • Table Product and Service Introduction of Changchun High tech

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of 3sbio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 3sbio

    • Figure Sales and Growth Rate Analysis of 3sbio

    • Figure Revenue and Market Share Analysis of 3sbio

    • Table Product and Service Introduction of 3sbio

    • Table Company Profile and Development Status of Sandoz

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz

    • Figure Sales and Growth Rate Analysis of Sandoz

    • Figure Revenue and Market Share Analysis of Sandoz

    • Table Product and Service Introduction of Sandoz

    • Table Company Profile and Development Status of Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lilly

    • Figure Sales and Growth Rate Analysis of Lilly

    • Figure Revenue and Market Share Analysis of Lilly

    • Table Product and Service Introduction of Lilly

    • Table Company Profile and Development Status of CP Guojian Pharmacy

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CP Guojian Pharmacy

    • Figure Sales and Growth Rate Analysis of CP Guojian Pharmacy

    • Figure Revenue and Market Share Analysis of CP Guojian Pharmacy

    • Table Product and Service Introduction of CP Guojian Pharmacy

    • Table Company Profile and Development Status of Gelgen Biopharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gelgen Biopharma

    • Figure Sales and Growth Rate Analysis of Gelgen Biopharma

    • Figure Revenue and Market Share Analysis of Gelgen Biopharma

    • Table Product and Service Introduction of Gelgen Biopharma

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Novo Nordisk

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk

    • Figure Sales and Growth Rate Analysis of Novo Nordisk

    • Figure Revenue and Market Share Analysis of Novo Nordisk

    • Table Product and Service Introduction of Novo Nordisk

    • Table Company Profile and Development Status of Biotech Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biotech Pharma

    • Figure Sales and Growth Rate Analysis of Biotech Pharma

    • Figure Revenue and Market Share Analysis of Biotech Pharma

    • Table Product and Service Introduction of Biotech Pharma

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US